Priority setting during the COVID-19 pandemic: going beyond vaccines
| dc.contributor.author | Williams I | |
| dc.contributor.author | Essue B | |
| dc.contributor.author | Nouvet E | |
| dc.contributor.author | Sandman L | |
| dc.contributor.author | Razavi SD | |
| dc.contributor.author | Noorulhuda M | |
| dc.contributor.author | Goold S | |
| dc.contributor.author | Danis M | |
| dc.contributor.author | Biemba G | |
| dc.contributor.author | Abelson J | |
| dc.contributor.author | Kapiriri L | |
| dc.date.accessioned | 2021-04-06T15:57:48Z | |
| dc.date.available | 2021-04-06T15:57:48Z | |
| dc.date.issued | 2021-01 | |
| dc.date.updated | 2021-04-06T15:57:47Z | |
| dc.identifier.doi | https://doi.org/10.1136/bmjgh-2020-004686 | |
| dc.identifier.issn | 2059-7908 | |
| dc.identifier.issn | 2059-7908 | |
| dc.identifier.uri | http://hdl.handle.net/11375/26285 | |
| dc.publisher | BMJ | |
| dc.rights | Attribution-NonCommercial - CC BY-NCAttribution-NonCommercial - CC BY-NC This Creative Commons license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don?t have to license their derivative works on the same terms. | |
| dc.rights.license | Attribution-NonCommercial - CC BY-NC | |
| dc.rights.uri | 6 | |
| dc.subject | COVID-19 | |
| dc.subject | health policy | |
| dc.subject | health systems | |
| dc.subject | vaccines | |
| dc.subject | COVID-19 | |
| dc.subject | COVID-19 Vaccines | |
| dc.subject | Cost-Benefit Analysis | |
| dc.subject | Decision Making | |
| dc.subject | Health Priorities | |
| dc.subject | Humans | |
| dc.subject | Pandemics | |
| dc.subject | SARS-CoV-2 | |
| dc.title | Priority setting during the COVID-19 pandemic: going beyond vaccines | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Priority setting during the COVID-19 pandemic going beyond vaccines.pdf
- Size:
- 254.32 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version